Literature DB >> 22474370

Mouse model recapitulating human Fcγ receptor structural and functional diversity.

Patrick Smith1, David J DiLillo, Stylianos Bournazos, Fubin Li, Jeffrey V Ravetch.   

Abstract

The in vivo biological activities of IgG antibodies result from their bifunctional nature, in which antigen recognition by the Fab is coupled to the effector and immunomodulatory diversity found in the Fc domain. This diversity, resulting from both amino acid and glycan heterogeneity, is translated into cellular responses through Fcγ receptors (FcγRs), a structurally and functionally diverse family of cell surface receptors found throughout the immune system. Although many of the overall features of this system are maintained throughout mammalian evolution, species diversity has precluded direct analysis of human antibodies in animal species, and, thus, detailed investigations into the unique features of the human IgG antibodies and their FcγRs have been limited. We now report the development of a mouse model in which all murine FcγRs have been deleted and human FcγRs, encoded as transgenes, have been inserted into the mouse genome resulting in recapitulation of the unique profile of human FcγR expression. These human FcγRs are shown to function to mediate the immunomodulatory, inflammatory, and cytotoxic activities of human IgG antibodies and Fc engineered variants and provide a platform for the detailed mechanistic analysis of therapeutic and pathogenic IgG antibodies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22474370      PMCID: PMC3341029          DOI: 10.1073/pnas.1203954109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Allelic polymorphisms of human Fc gamma receptor IIA and Fc gamma receptor IIIB. Independent mechanisms for differences in human phagocyte function.

Authors:  J E Salmon; J C Edberg; N L Brogle; R P Kimberly
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

2.  Epidermal growth factor receptor (EGFR) antibody-induced antibody-dependent cellular cytotoxicity plays a prominent role in inhibiting tumorigenesis, even of tumor cells insensitive to EGFR signaling inhibition.

Authors:  Marije B Overdijk; Sandra Verploegen; Jeroen H van den Brakel; Jeroen J Lammerts van Bueren; Tom Vink; Jan G J van de Winkel; Paul W H I Parren; Wim K Bleeker
Journal:  J Immunol       Date:  2011-08-10       Impact factor: 5.422

3.  Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets.

Authors:  R A Clynes; T L Towers; L G Presta; J V Ravetch
Journal:  Nat Med       Date:  2000-04       Impact factor: 53.440

4.  Molecular basis for a polymorphism of human Fc gamma receptor II (CD32).

Authors:  P A Warmerdam; J G van de Winkel; E J Gosselin; P J Capel
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

Review 5.  FcgammaR polymorphisms: Implications for function, disease susceptibility and immunotherapy.

Authors:  N M van Sorge; W-L van der Pol; J G J van de Winkel
Journal:  Tissue Antigens       Date:  2003-03

6.  The Fc receptor, FcRI, and other activation molecules on human mononuclear phagocytes after treatment with interferon-gamma.

Authors:  Y Jayaram; A M Buckle; N Hogg
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

7.  Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice.

Authors:  I A Heijnen; M J van Vugt; N A Fanger; R F Graziano; T P de Wit; F M Hofhuis; P M Guyre; P J Capel; J S Verbeek; J G van de Winkel
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

8.  Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.

Authors:  K Inaba; M Inaba; N Romani; H Aya; M Deguchi; S Ikehara; S Muramatsu; R M Steinman
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

9.  Reconstitution of human Fc gamma RIII cell type specificity in transgenic mice.

Authors:  M Li; U Wirthmueller; J V Ravetch
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

10.  Alternative membrane forms of Fc gamma RIII(CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions.

Authors:  J V Ravetch; B Perussia
Journal:  J Exp Med       Date:  1989-08-01       Impact factor: 14.307

View more
  129 in total

1.  Apoptotic and antitumor activity of death receptor antibodies require inhibitory Fcγ receptor engagement.

Authors:  Fubin Li; Jeffrey V Ravetch
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-20       Impact factor: 11.205

2.  Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection.

Authors:  David J DiLillo; Peter Palese; Patrick C Wilson; Jeffrey V Ravetch
Journal:  J Clin Invest       Date:  2016-01-05       Impact factor: 14.808

Review 3.  The Role and Function of Fcγ Receptors on Myeloid Cells.

Authors:  Stylianos Bournazos; Taia T Wang; Jeffrey V Ravetch
Journal:  Microbiol Spectr       Date:  2016-12

Review 4.  Beyond Viral Neutralization.

Authors:  George K Lewis; Marzena Pazgier; David T Evans; Guido Ferrari; Stylianos Bournazos; Matthew S Parsons; Nicole F Bernard; Andrés Finzi
Journal:  AIDS Res Hum Retroviruses       Date:  2017-02-16       Impact factor: 2.205

5.  Antibodies targeting sialyl Lewis A mediate tumor clearance through distinct effector pathways.

Authors:  Polina Weitzenfeld; Stylianos Bournazos; Jeffrey V Ravetch
Journal:  J Clin Invest       Date:  2019-09-03       Impact factor: 14.808

6.  Monocyte recruitment by HLA IgG-activated endothelium: the relationship between IgG subclass and FcγRIIa polymorphisms.

Authors:  N M Valenzuela; K R Trinh; A Mulder; S L Morrison; E F Reed
Journal:  Am J Transplant       Date:  2015-02-03       Impact factor: 8.086

7.  Characterization of Mauritian Cynomolgus Macaque FcγR Alleles Using Long-Read Sequencing.

Authors:  Amelia K Haj; Jaren M Arbanas; Aaron P Yamniuk; Julie A Karl; Hailey E Bussan; Kenneth Y Drinkwater; Michael E Graham; Adam J Ericsen; Trent M Prall; Kristina Moore; Lin Cheng; Mian Gao; Robert F Graziano; John T Loffredo; Roger W Wiseman; David H O'Connor
Journal:  J Immunol       Date:  2018-12-10       Impact factor: 5.422

8.  Human IgG Fc domain engineering enhances antitoxin neutralizing antibody activity.

Authors:  Stylianos Bournazos; Siu-Kei Chow; Nareen Abboud; Arturo Casadevall; Jeffrey V Ravetch
Journal:  J Clin Invest       Date:  2014-01-09       Impact factor: 14.808

9.  Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo.

Authors:  Ching-Lan Lu; Dariusz K Murakowski; Stylianos Bournazos; Till Schoofs; Debolina Sarkar; Ariel Halper-Stromberg; Joshua A Horwitz; Lilian Nogueira; Jovana Golijanin; Anna Gazumyan; Jeffrey V Ravetch; Marina Caskey; Arup K Chakraborty; Michel C Nussenzweig
Journal:  Science       Date:  2016-05-05       Impact factor: 47.728

10.  Human FcγRII cytoplasmic domains differentially influence antibody-mediated dengue virus infection.

Authors:  Kobporn Boonnak; Bonnie M Slike; Gina C Donofrio; Mary A Marovich
Journal:  J Immunol       Date:  2013-04-24       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.